Cargando…
Retracted: Research Progress of B-Cell Lymphoma/Leukemia-2 Inhibitor Combined with Azacytidine in the Targeted Therapy of Acute Myeloid Leukemia
Autor principal: | Methods in Medicine, Computational and Mathematical |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567502/ https://www.ncbi.nlm.nih.gov/pubmed/37829540 http://dx.doi.org/10.1155/2023/9837485 |
Ejemplares similares
-
Retracted: Second-Generation Tyrosine Kinase Inhibitor Discontinuation in Chronic Myeloid Leukemia Patients with Stable Deep Molecular Response: A Systematic Review and a Meta-Analysis
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023) -
Retracted: Genomic and Clinical Analysis of Children with Acute Lymphoblastic Leukemia
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023) -
Retracted: Influencing Factors and Coping Strategies of Hospitalization in Children with Leukemia Complicated with Pneumonia
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023) -
Retracted: Role and Mechanism of lncRNA-pvt1 in the Pathogenesis of Acute Lymphoblastic Leukemia in Children
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023) -
Retracted: A Multicenter Cohort Study on Children Suffering from Acute Lymphoblastic Leukemia: Effects of Obesity on Mortality
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)